CHART OF THE DAY: Ozempic Maker Novo Nordisk Is Biggest Company in Europe

Ozempic Maker Novo Nordisk Shares Rise as Stock Split Adds to Liquidity - Bloomberg

Ozempic maker overtook LVMH as Europe's most valuable company

The “magic medicine for weight loss” has taken the world by storm, and the stock market has been shocked

Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates

Ozempic and Wegovy: Novo Nordisk Obesity Drugs Ripple Through Stock Markets - Bloomberg

Chartr Newsletter: Aug 30, 2023

Is Semaglutide - Novo Nordisk's Keytruda?

Ozempic maker Novo Nordisk isn't just Europe's second-most valuable company. It is also singlehandedly boosting Denmark's economy.

Novo Nordisk Sales Soar, Fortifying Grip on Obesity Drug Market - Bloomberg

Novo Nordisk (NOVOB) Briefly Overtakes LVMH (MC) as Biggest European Company - Bloomberg

How Investors Are Capitalizing On The Ozempic And Wegovy Craze

Prescriptions for popular diabetes and weight-loss drugs soared, but access is limited for some patients

Ozempic craze sends shares of junk food companies plunging - with stock in the makers of Jell-O, Fritos and Pringles all hitting new one-year lows

Novo Nordisk (NVO) Stock: Attractive Market But Likely No Margin Of Safety